NVAX

NOVAVAX INC

Healthcare | Small Cap

-$0.89

EPS Forecast

$47.1

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
REPLReplimune Group IncTECHBio-techne CorpCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncNBIXNeurocrine Biosciences IncRGENRepligen CorpMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics Inc